Titre : Pectinidae

Pectinidae : Questions médicales fréquentes

Termes MeSH sélectionnés :

Datasets as Topic
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Pectinidae : Questions médicales les plus fréquentes", "headline": "Pectinidae : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Pectinidae : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-04-04", "dateModified": "2025-03-30", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Pectinidae" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Bivalvia", "url": "https://questionsmedicales.fr/mesh/D049872", "about": { "@type": "MedicalCondition", "name": "Bivalvia", "code": { "@type": "MedicalCode", "code": "D049872", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "B01.050.500.644.080" } } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Pecten", "alternateName": "Pecten", "url": "https://questionsmedicales.fr/mesh/D049910", "about": { "@type": "MedicalCondition", "name": "Pecten", "code": { "@type": "MedicalCode", "code": "D049910", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "B01.050.500.644.080.660.600" } } } ], "about": { "@type": "MedicalCondition", "name": "Pectinidae", "alternateName": "Pectinidae", "code": { "@type": "MedicalCode", "code": "D049897", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Tamás Malkócs", "url": "https://questionsmedicales.fr/author/Tam%C3%A1s%20Malk%C3%B3cs", "affiliation": { "@type": "Organization", "name": "Littoral Environnement et Sociétés (LIENSs), UMR 7266, CNRS-Université de La Rochelle, 2 Rue Olympe de Gouges, 17042, La Rochelle Cedex 01, France. tamas.malkocs@gmail.com." } }, { "@type": "Person", "name": "Amélia Viricel", "url": "https://questionsmedicales.fr/author/Am%C3%A9lia%20Viricel", "affiliation": { "@type": "Organization", "name": "Littoral Environnement et Sociétés (LIENSs), UMR 7266, CNRS-Université de La Rochelle, 2 Rue Olympe de Gouges, 17042, La Rochelle Cedex 01, France." } }, { "@type": "Person", "name": "Vanessa Becquet", "url": "https://questionsmedicales.fr/author/Vanessa%20Becquet", "affiliation": { "@type": "Organization", "name": "Littoral Environnement et Sociétés (LIENSs), UMR 7266, CNRS-Université de La Rochelle, 2 Rue Olympe de Gouges, 17042, La Rochelle Cedex 01, France." } }, { "@type": "Person", "name": "Louise Evin", "url": "https://questionsmedicales.fr/author/Louise%20Evin", "affiliation": { "@type": "Organization", "name": "Littoral Environnement et Sociétés (LIENSs), UMR 7266, CNRS-Université de La Rochelle, 2 Rue Olympe de Gouges, 17042, La Rochelle Cedex 01, France." } }, { "@type": "Person", "name": "Emmanuel Dubillot", "url": "https://questionsmedicales.fr/author/Emmanuel%20Dubillot", "affiliation": { "@type": "Organization", "name": "Littoral Environnement et Sociétés (LIENSs), UMR 7266, CNRS-Université de La Rochelle, 2 Rue Olympe de Gouges, 17042, La Rochelle Cedex 01, France." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Long-term efficacy (up to 68 weeks) of Baricitinib in combination with topical corticosteroids in adult patients with moderate-to-severe atopic dermatitis: Analysis of treatment responders, partial responders and nonresponders originating from study BREEZE-AD7.", "datePublished": "2023-01-20", "url": "https://questionsmedicales.fr/article/36514996", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1111/jdv.18816" } }, { "@type": "ScholarlyArticle", "name": "Twitter-Based Sentiment Analysis and Topic Modeling of Social Media Posts Using Natural Language Processing, to Understand People's Perspectives Regarding COVID-19 Booster Vaccine Shots in India: Crucial to Expanding Vaccination Coverage.", "datePublished": "2022-11-15", "url": "https://questionsmedicales.fr/article/36423024", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3390/vaccines10111929" } }, { "@type": "ScholarlyArticle", "name": "UK Nutrition Research Partnership 'Hot Topic' workshop: Vitamin D-A multi-disciplinary approach to (1) elucidate its role in human health and (2) develop strategies to improve vitamin D status in the UK population.", "datePublished": "2022-05-27", "url": "https://questionsmedicales.fr/article/36045095", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1111/nbu.12557" } }, { "@type": "ScholarlyArticle", "name": "Application of convex hull analysis for the evaluation of data heterogeneity between patient populations of different origin and implications of hospital bias in downstream machine-learning-based data processing: A comparison of 4 critical-care patient datasets.", "datePublished": "2022-10-31", "url": "https://questionsmedicales.fr/article/36387013", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3389/fdata.2022.603429" } }, { "@type": "ScholarlyArticle", "name": "Pharmacovigilance Signals of the Opioid Epidemic over 10 Years: Data Mining Methods in the Analysis of Pharmacovigilance Datasets Collecting Adverse Drug Reactions (ADRs) Reported to EudraVigilance (EV) and the FDA Adverse Event Reporting System (FAERS).", "datePublished": "2022-05-27", "url": "https://questionsmedicales.fr/article/35745593", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3390/ph15060675" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Eucaryotes", "item": "https://questionsmedicales.fr/mesh/D056890" }, { "@type": "ListItem", "position": 3, "name": "Animaux", "item": "https://questionsmedicales.fr/mesh/D000818" }, { "@type": "ListItem", "position": 4, "name": "Invertébrés", "item": "https://questionsmedicales.fr/mesh/D007448" }, { "@type": "ListItem", "position": 5, "name": "Mollusca", "item": "https://questionsmedicales.fr/mesh/D008974" }, { "@type": "ListItem", "position": 6, "name": "Bivalvia", "item": "https://questionsmedicales.fr/mesh/D049872" }, { "@type": "ListItem", "position": 7, "name": "Pectinidae", "item": "https://questionsmedicales.fr/mesh/D049897" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Pectinidae - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Pectinidae", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-06", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Pectinidae", "description": "Comment identifier les Pectinidae ?\nQuels outils pour le diagnostic des Pectinidae ?\nY a-t-il des tests spécifiques pour les Pectinidae ?\nLes Pectinidae sont-ils faciles à identifier ?\nPeut-on confondre les Pectinidae avec d'autres espèces ?", "url": "https://questionsmedicales.fr/mesh/D049897?mesh_terms=Datasets+as+Topic&page=820#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Pectinidae", "description": "Quels sont les symptômes d'une allergie aux Pectinidae ?\nLes Pectinidae causent-ils des intoxications ?\nQuels signes d'infection après consommation de Pectinidae ?\nLes Pectinidae provoquent-ils des douleurs ?\nComment reconnaître une réaction allergique aux Pectinidae ?", "url": "https://questionsmedicales.fr/mesh/D049897?mesh_terms=Datasets+as+Topic&page=820#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Pectinidae", "description": "Comment prévenir les allergies aux Pectinidae ?\nQuelles précautions pour éviter l'intoxication alimentaire ?\nComment choisir des Pectinidae en toute sécurité ?\nY a-t-il des recommandations pour la consommation de Pectinidae ?\nComment stocker les Pectinidae en toute sécurité ?", "url": "https://questionsmedicales.fr/mesh/D049897?mesh_terms=Datasets+as+Topic&page=820#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Pectinidae", "description": "Quel traitement pour une allergie aux Pectinidae ?\nComment traiter une intoxication alimentaire par Pectinidae ?\nY a-t-il un antidote pour les intoxications aux Pectinidae ?\nComment gérer les symptômes d'une réaction allergique ?\nQuand consulter un médecin après consommation de Pectinidae ?", "url": "https://questionsmedicales.fr/mesh/D049897?mesh_terms=Datasets+as+Topic&page=820#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Pectinidae", "description": "Quelles complications peuvent survenir après une intoxication ?\nLes allergies aux Pectinidae peuvent-elles être graves ?\nQuelles sont les conséquences d'une consommation excessive ?\nLes infections liées aux Pectinidae peuvent-elles être graves ?\nComment les complications sont-elles traitées ?", "url": "https://questionsmedicales.fr/mesh/D049897?mesh_terms=Datasets+as+Topic&page=820#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Pectinidae", "description": "Qui est à risque d'allergies aux Pectinidae ?\nQuels sont les risques liés à la consommation de Pectinidae ?\nLes enfants sont-ils plus à risque ?\nY a-t-il des facteurs environnementaux à considérer ?\nComment les habitudes alimentaires influencent-elles les risques ?", "url": "https://questionsmedicales.fr/mesh/D049897?mesh_terms=Datasets+as+Topic&page=820#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment identifier les Pectinidae ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Les Pectinidae se reconnaissent par leur coquille en forme de cœur et leurs stries radiales." } }, { "@type": "Question", "name": "Quels outils pour le diagnostic des Pectinidae ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "L'examen visuel et la classification taxonomique sont essentiels pour identifier les espèces." } }, { "@type": "Question", "name": "Y a-t-il des tests spécifiques pour les Pectinidae ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Il n'existe pas de tests spécifiques, l'identification repose sur l'observation morphologique." } }, { "@type": "Question", "name": "Les Pectinidae sont-ils faciles à identifier ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Oui, leur forme et leur couleur distinctives facilitent leur identification sur le terrain." } }, { "@type": "Question", "name": "Peut-on confondre les Pectinidae avec d'autres espèces ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certaines espèces de bivalves peuvent être similaires, nécessitant une identification précise." } }, { "@type": "Question", "name": "Quels sont les symptômes d'une allergie aux Pectinidae ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent démangeaisons, éruptions cutanées et troubles respiratoires." } }, { "@type": "Question", "name": "Les Pectinidae causent-ils des intoxications ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une consommation de Pectinidae contaminés peut entraîner des intoxications alimentaires." } }, { "@type": "Question", "name": "Quels signes d'infection après consommation de Pectinidae ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Des symptômes comme nausées, vomissements et diarrhée peuvent indiquer une infection." } }, { "@type": "Question", "name": "Les Pectinidae provoquent-ils des douleurs ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Des douleurs abdominales peuvent survenir en cas d'intoxication ou d'allergie." } }, { "@type": "Question", "name": "Comment reconnaître une réaction allergique aux Pectinidae ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Une réaction allergique se manifeste par des démangeaisons, des rougeurs et un gonflement." } }, { "@type": "Question", "name": "Comment prévenir les allergies aux Pectinidae ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Évitez la consommation de Pectinidae si vous avez des antécédents d'allergies alimentaires." } }, { "@type": "Question", "name": "Quelles précautions pour éviter l'intoxication alimentaire ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Assurez-vous que les Pectinidae sont bien cuits et proviennent de sources sûres." } }, { "@type": "Question", "name": "Comment choisir des Pectinidae en toute sécurité ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Choisissez des Pectinidae frais, sans odeur désagréable et avec des coquilles fermées." } }, { "@type": "Question", "name": "Y a-t-il des recommandations pour la consommation de Pectinidae ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Limitez la consommation de Pectinidae provenant de zones polluées pour éviter les risques." } }, { "@type": "Question", "name": "Comment stocker les Pectinidae en toute sécurité ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Conservez-les au réfrigérateur et consommez-les rapidement pour éviter la détérioration." } }, { "@type": "Question", "name": "Quel traitement pour une allergie aux Pectinidae ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Le traitement inclut des antihistaminiques et l'évitement des Pectinidae." } }, { "@type": "Question", "name": "Comment traiter une intoxication alimentaire par Pectinidae ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Le traitement consiste en une réhydratation et, si nécessaire, des soins médicaux d'urgence." } }, { "@type": "Question", "name": "Y a-t-il un antidote pour les intoxications aux Pectinidae ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Il n'existe pas d'antidote spécifique, le traitement est symptomatique." } }, { "@type": "Question", "name": "Comment gérer les symptômes d'une réaction allergique ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "L'utilisation d'antihistaminiques et de corticostéroïdes peut aider à soulager les symptômes." } }, { "@type": "Question", "name": "Quand consulter un médecin après consommation de Pectinidae ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Consultez un médecin si des symptômes graves ou persistants apparaissent après consommation." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir après une intoxication ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Des complications comme la déshydratation et des troubles gastro-intestinaux peuvent survenir." } }, { "@type": "Question", "name": "Les allergies aux Pectinidae peuvent-elles être graves ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des réactions allergiques sévères peuvent entraîner un choc anaphylactique." } }, { "@type": "Question", "name": "Quelles sont les conséquences d'une consommation excessive ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Une consommation excessive peut entraîner des troubles digestifs et des carences nutritionnelles." } }, { "@type": "Question", "name": "Les infections liées aux Pectinidae peuvent-elles être graves ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certaines infections peuvent nécessiter une hospitalisation et un traitement intensif." } }, { "@type": "Question", "name": "Comment les complications sont-elles traitées ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Les complications sont traitées selon leur nature, souvent par des soins symptomatiques." } }, { "@type": "Question", "name": "Qui est à risque d'allergies aux Pectinidae ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les personnes ayant des antécédents d'allergies alimentaires sont plus à risque." } }, { "@type": "Question", "name": "Quels sont les risques liés à la consommation de Pectinidae ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Les risques incluent des allergies, des intoxications et des infections alimentaires." } }, { "@type": "Question", "name": "Les enfants sont-ils plus à risque ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les enfants peuvent être plus sensibles aux allergies alimentaires et aux intoxications." } }, { "@type": "Question", "name": "Y a-t-il des facteurs environnementaux à considérer ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, la pollution de l'eau et la qualité des habitats marins influencent les risques." } }, { "@type": "Question", "name": "Comment les habitudes alimentaires influencent-elles les risques ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Une consommation fréquente de Pectinidae augmente le risque d'allergies et d'intoxications." } } ] } ] }

Sources (8215 au total)

Long-term efficacy (up to 68 weeks) of Baricitinib in combination with topical corticosteroids in adult patients with moderate-to-severe atopic dermatitis: Analysis of treatment responders, partial responders and nonresponders originating from study BREEZE-AD7.

Baricitinib demonstrated efficacy in treating adults with moderate-to-severe atopic dermatitis (AD) in Phase 3 clinical trials.... To examine long-term efficacy of baricitinib combined with topical corticosteroids (TCS) in adult patients from a Phase 3 study, BREEZE-AD7 (NCT03733301), enrolled in ongoing extension study, BREEZE-A... Upon BREEZE-AD7 completion, responders or partial responders (RPR [vIGA-AD™ ≤2]) receiving baricitinib 2-mg or 4-mg + TCS maintained their original treatment doses in BREEZE-AD3. Nonresponders (NR; vI... In baricitinib 4-mg ITT cohort (N = 102), proportions of patients achieving vIGA-AD (0,1) at Week 32, Week 52, and Week 68 were 21.6%, 26.5% and 23.5%; EASI75 were 46.1%, 40.2% and 43.1%, respectively... Baricitinib 4-mg and 2-mg combined with TCS maintained clinically meaningful sustained efficacy over 68 weeks of continuous treatment....

Twitter-Based Sentiment Analysis and Topic Modeling of Social Media Posts Using Natural Language Processing, to Understand People's Perspectives Regarding COVID-19 Booster Vaccine Shots in India: Crucial to Expanding Vaccination Coverage.

This study analyzed perceptions of Indians regarding COVID-19 booster dose vaccines using natural language processing techniques, particularly, sentiment analysis and topic modeling. We analyzed tweet...

UK Nutrition Research Partnership 'Hot Topic' workshop: Vitamin D-A multi-disciplinary approach to (1) elucidate its role in human health and (2) develop strategies to improve vitamin D status in the UK population.

Vitamin D is truly unique-not a 'vital' amine in the true sense of the word, but rather a prohormone, which is produced in the skin during exposure to sunlight (UVB radiation at 290-315 nm) and which ...

Application of convex hull analysis for the evaluation of data heterogeneity between patient populations of different origin and implications of hospital bias in downstream machine-learning-based data processing: A comparison of 4 critical-care patient datasets.

Machine learning (ML) models are developed on a learning dataset covering only a small part of the data of interest. If model predictions are accurate for the learning dataset but fail for unseen data...

Pharmacovigilance Signals of the Opioid Epidemic over 10 Years: Data Mining Methods in the Analysis of Pharmacovigilance Datasets Collecting Adverse Drug Reactions (ADRs) Reported to EudraVigilance (EV) and the FDA Adverse Event Reporting System (FAERS).

In the past twenty years, the consumption of opioid medications has reached significant proportions, leading to a rise in drug misuse and abuse and increased opioid dependence and related fatalities. ...

Association Between Care Fragmentation and Total Spending After Durable Left Ventricular Device Implant: A Mediation Analysis of Health Care-Associated Infections Within a National Medicare-Society of Thoracic Surgeons Intermacs Linked Dataset.

Care fragmentation is associated with higher rates of infection after durable left ventricular assist device (LVAD) implant. Less is known about the relationship between care fragmentation and total s... Total payments were captured from admission to 180 days post-discharge. Drawing on network theory, a measure of care fragmentation was developed based on the number of shared patients among providers ... The patient cohort was 81% male, 73% white, 11% Intermacs Profile 1 with mean (SD) age of 63.1 years (11.1). The mean (SD) level of care fragmentation in provider networks was 1.7 (0.2) and mean (SD) ... Greater care fragmentation in the delivery of care surrounding durable LVAD implantation is associated with a higher incidence of infections, and consequently, higher payments for Medicare beneficiari...

Eyes on Topical Ocular Disposition: The Considered Design of a Lead Janus Kinase (JAK) Inhibitor That Utilizes a Unique Azetidin-3-Amino Bridging Scaffold to Attenuate Off-Target Kinase Activity, While Driving Potency and Aqueous Solubility.

An unmet medical need remains for patients suffering from dry eye disease (DED). A fast-acting, better-tolerated noncorticosteroid anti-inflammatory eye drop could improve patient outcomes and quality...

Study protocol for a phase 1, randomised, double-blind, placebo-controlled study to investigate the safety, tolerability and pharmacokinetics of ascending topical doses of TCP-25 applied to epidermal suction blister wounds in healthy male and female volunteers.

TCP-25 gel is intended for use in treatment of wound infection and inflammation. Current local therapies for wounds have limited efficacy to prevent infections and there are no wound treatments availa... A randomised, double-blinded, first-in-human study was designed to evaluate the safety, tolerability and potential systemic exposure of three increasing doses of the TCP-25 gel applied topically on su... The study will be performed in accordance with ethical principles consistent with the Declaration of Helsinki, ICH/GCPE6 (R2), European Union Clinical Trials Directive and applicable local regulatory ... NCT05378997....

High-Throughput Proteomic Analysis of Human Dermal Fibroblast Response to Different Blood Derivatives: Autologous Topical Serum Derived from Plasma Rich in Growth Factors (PRGF) versus Leukocyte- and Platelet-Rich Plasma (L-PRP).

Platelet-rich plasma (PRP) is nowadays used in the treatment of different types of cutaneous lesions. However, different compositions can influence clinical outcomes. Among them, the inclusion of leuk...